Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference

Castle Biosciences (Nasdaq: CSTL) announced that its executive management will present a company overview at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time.

Rhea-AI Summary

Castle Biosciences (Nasdaq: CSTL) announced that its executive management will present a company overview at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time. A live audio webcast and subsequent replay will be accessible via the company’s investor relations events webpage.

Argus Jul 22 session

+1.22% close to close Open Argus

Details

News Market Reaction – CSTL

On Jul 22, the day this news came out, CSTL closed 1.22% above the previous close.

Data tracked by StockTitan Argus for the Jul 22 session.

Market Context

Recent insider activity was Net Selling, with 0 shares bought and 13,993 sold during the analyzed pe...

Analysis

Recent insider activity was Net Selling, with 0 shares bought and 13,993 sold during the analyzed period. The announcement provides scheduling information rather than operating results; subsequent disclosures supply the substantive comparison.

Key Figures

Conference edition: 46th annual Presentation date: Aug. 12, 2026 Presentation time: 11:30 a.m. Eastern time

Conference edition

46th annual

Canaccord Genuity Growth Conference

Presentation date

Aug. 12, 2026

Scheduled conference presentation

Presentation time

11:30 a.m. Eastern time

Scheduled conference presentation

Historical Context

5 past events · Latest: Jul 14

5 events

1. Jul 14

   NYSDOH test approval

   24h Move

   +3.9%

   NYSDOH approved AdvanceAD-Tx assay for systemic therapy selection in atopic dermatitis patients.

2. Jul 09

   Earnings date announcement

   24h Move

   +3.9%

   Company scheduled second-quarter financial-results release and management webcast for July 30.

3. Jun 25

   Clinical data release

   24h Move

   +6.1%

   Prospective DECIDE study showed i31-SLNB outperformed MIA nomogram in melanoma risk prediction.

4. Jun 23

   CFO recognition

   24h Move

   +0.8%

   CFO Frank Stokes received recognition among 22 Greater Houston financial leaders.

5. Jun 16

   Order milestone

   24h Move

   -1.0%

   TissueCypher surpassed 100,000 clinical orders for Barrett's esophagus risk assessment.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRIENDSWOOD, Texas, July 22, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 46^th Annual Growth Conference on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time.

A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/ir-events. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com 

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference-302831101.html

SOURCE Castle Biosciences, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Castle Biosciences (CSTL) present at the Canaccord Genuity 46th Annual Growth Conference?

Castle Biosciences is scheduled to present on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time. According to Castle Biosciences, executive management will provide a company overview during this session at the Canaccord Genuity 46th Annual Growth Conference.

How can investors listen to Castle Biosciences’ CSTL presentation at the Canaccord Genuity 2026 conference?

Investors can listen via a live audio webcast available on Castle Biosciences’ investor relations events page. According to Castle Biosciences, access is provided through https://ir.castlebiosciences.com/news-events/ir-events at the time of the presentation.

Will there be a replay of Castle Biosciences’ (CSTL) Canaccord Genuity conference presentation?

Yes, a replay of the webcast will be available after the live broadcast concludes. According to Castle Biosciences, investors can access the replay through the same investor relations events section on the company’s website used for the live audio webcast.

What will Castle Biosciences’ management present at the Canaccord Genuity 46th Annual Growth Conference?

Castle Biosciences’ executive management will present a company overview at the conference. According to Castle Biosciences, the session will focus on the company’s business, which centers on innovative diagnostic tests that guide patient care decisions.

Where can I find the link to Castle Biosciences’ (CSTL) conference webcast on August 12, 2026?

The webcast link will be available on Castle Biosciences’ investor relations news and events page. According to Castle Biosciences, investors should visit https://ir.castlebiosciences.com/news-events/ir-events to access both the live audio webcast and the replay.